Inflammation and hypoalbuminemia mediate the association between CKD and contrast-associated AKI
Abstract
Objective: Chronic kidney disease (CKD) is associated with an increased risk of contrast-associated acute kidney injury (CA-AKI), but the pathways underlying this relationship, including the contribution of intermediate factors, are not well characterized. We investigated the association between CKD and CA-AKI in patients undergoing coronary angiography or percutaneous coronary intervention and evaluated the potential mediating roles of serum albumin and high-sensitivity C-reactive protein (hsCRP) in this association.
Methods: During the study period, a total of 13,024 patients underwent coronary angiography of these, 3740 met the predefined inclusion criteria and formed the final study cohort. Multivariable logistic regression and formal mediation analyses were subsequently employed to evaluate the associations of interest.
Results: Among the 3740 patients, 414 (11.1%) developed CA-AKI. Lower pre-procedural serum albumin and higher log-transformed hsCRP (LnhsCRP) were independently associated with increased CA-AKI risk (OR [95% CI] 0.730 [0.583-0.913], P = 0.006, and 1.385 [1.215-1.579], P < 0.001, respectively). The initial association between CKD and CA-AKI (OR 1.906 [1.552-2.342]) was attenuated after adjustment for albumin and hsCRP (OR 1.253 [0.975-1.609]). Subsequent mediation analysis indicated that serum albumin and hsCRP statistically accounted for approximately 31.3% and 56.6% of the attenuation in the association between CKD and CA-AKI, with an additional…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 13,024 participants or records.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.